Published in Cancer Weekly, March 16th, 2004
Third Wave's new approach to chromosomal analysis is easier to use and more cost-effective than traditional methods, while providing clinicians with objective, same-day results.
In conjunction with this important extension of the Invader technology, Third Wave also announced it is providing Invader analyte-specific reagents (ASRs) for prenatal chromosomal analysis to the university of California, Los Angeles (UCLA) and other leading institutions under an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.